On June 10, 2022, the FDA issued a warning letter to Young Living Essential Oils Corporate after an inspection of the company’s website and social media found statements about the company’s essential oil and CBD products to be drug claims.

For example, the company’s website promoted its Lemon Essential Oil with statements such as, “…sometimes proves to be as effective as stone-breaking chanca piedra pills for the kidney stones.” and “Use (especially along with lavender and peppermint) to ease those seasonal sniffles and runny noses.” Video images also promoted products such as Frankincense Essential Oil with statements such as “…can help with arthritis…asthma.”

The company was also warned for promoting its CBD products, Nature’s Ultra CBD, for conditions ranging from Alzheimer’s disease, diabetes, and glaucoma to sleep disorders, anxiety, depression, and PTSD. For example, the company used statements such as “When thinking of emotional wellness…[a] lot of people may think about mental health issues, such as depression or PTSD…[h]ow [c]an it be [i]mproved?…[y]ou can also try to encourage a positive and relaxing atmosphere throughout the day by using your favorite scents or oils! We highly recommend our Cinnamon CBD Oil.”

In addition, the products are misbranded because product labels do not bear adequate directions for intended use.

Young Living Essential Oils Corporate has 15 days to respond to the FDA in writing to explain the specific steps taken to address any and all violations. Failure to properly address violations could result in legal action such as limitation, seizure, and injunction.

For information and tests of related products, see ConsumerLab’s CBD & Hemp Extract Supplements, Lotions, and Balms Review.

Also see ConsumerLab’s answers to the questions: Can any supplements reduce or increase the risk of kidney stones? and Which supplements are best for seasonal allergies?

Be aware that essential oils used as vapors may result in an increased risk of seizures, respiratory infections, and exacerbated asthma in some people.

ConsumerLab is currently testing essential oil products and will be reporting results in mid-2022.

For more information, use the link below.

Warning: Young Living Essential Oils Corporate

See related recalls and warnings:

Poisoning from Essential Oils Increasing

Complaint Submitted to FTC for doTerra Essential Oil COVID Claims

CBD Products Were Promoted to Treat Cancer and Alzheimer’s Without Proof, Says FTC

Seller of CBD Tinctures, Creams & Pet Products Promoted for Pain, Cancer & More Warned by FDA

FTC Takes Further Action Against Deceptive CBD Claims